We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+27.94%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$40.4B
AUM Growth
+$6.4B
(+19%)
Cap. Flow
-$900M
Cap. Flow
% of AUM
-2.23%
Top 10 Holdings %
Top 10 Hldgs %
16.03%
Holding
2,489
New
261
Increased
810
Reduced
1,082
Closed
259
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$245M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$143M |
| 3 |
3M
MMM
|
+$142M |
| 4 |
Public Service Enterprise Group
PEG
|
+$108M |
| 5 |
KeyCorp
KEY
|
+$80.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$378M |
| 2 |
Kimberly-Clark
KMB
|
+$186M |
| 3 |
Altria Group
MO
|
+$141M |
| 4 |
AbbVie
ABBV
|
+$141M |
| 5 |
Pfizer
PFE
|
+$120M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.35% |
| 2 | Technology | 19% |
| 3 | Consumer Discretionary | 10.55% |
| 4 | Financials | 9.89% |
| 5 | Communication Services | 7.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Citigroup
C
$228B
| $63.6M | 0.16% |
1,244,888
+50,395
| +4% | +$2.39M |
|
152
Berkshire Hathaway Class B
BRK.B
$1.1T
| $63.1M | 0.16% |
353,266
-134,563
| -28% | -$24.6M |
|
153
Steris
STE
$20.8B
| $62.9M | 0.16% |
409,844
-56,881
| -12% | -$8.66M |
|
154
Apollo Global Management
APO
$75.8B
| $62.3M | 0.15% |
1,248,278
-11,514
| -0.9% | -$505K |
|
155
WEX
WEX
$6.84B
| $61.8M | 0.15% |
374,628
-75,044
| -17% | -$10.3M |
|
156
Genpact
G
$6.12B
| $61M | 0.15% |
1,670,899
+147,836
| +10% | +$5M |
|
157
AptarGroup
ATR
$7.94B
| $59.8M | 0.15% |
534,445
-82,052
| -13% | -$8.73M |
|
158
Enovis
ENOV
$1.05B
| $59.8M | 0.15% |
1,244,819
+496,845
| +66% | +$21.9M |
|
159
Freshpet
FRPT
$3.06B
| $59.5M | 0.15% |
710,706
+140,631
| +25% | +$10.6M |
|
160
Ares Management
ARES
$29.9B
| $59M | 0.15% |
1,485,000
+150,000
| +11% | +$5.3M |
|
161
Wintrust Financial
WTFC
$10.3B
| $58.6M | 0.15% |
1,344,521
-31,127
| -2% | -$1.24M |
|
162
Amphastar Pharmaceuticals
AMPH
$1.02B
| $58.4M | 0.14% |
2,600,107
-13
| -0% | -$238 |
|
|
ZGNX
163
DELISTED
Zogenix, Inc.
ZGNX
| $57.8M | 0.14% |
2,141,016
+75,882
| +4% | +$2.09M |
|
|
MGP
164
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
| $57.8M | 0.14% |
2,123,100
+230,605
| +12% | +$5.94M |
|
165
Edwards Lifesciences
EW
$49.3B
| $57.7M | 0.14% |
834,670
-16,433
| -2% | -$1.17M |
|
166
Kinross Gold
KGC
$33.4B
| $57.6M | 0.14% |
7,979,061
| – | – |
|
167
PayPal
PYPL
$46.2B
| $57.5M | 0.14% |
330,220
+129,363
| +64% | +$17.9M |
|
168
Grocery Outlet
GO
$1.16B
| $57.4M | 0.14% |
1,406,212
+527,476
| +60% | +$18.9M |
|
169
Humana
HUM
$48.9B
| $56.9M | 0.14% |
146,617
+52,426
| +56% | +$19.6M |
|
170
Huntington Bancshares
HBAN
$33.9B
| $56.6M | 0.14% |
6,264,187
-300,040
| -5% | -$2.66M |
|
|
ATVI
171
DELISTED
Activision Blizzard
ATVI
| $56.4M | 0.14% |
743,249
+710,343
| +2,159% | +$49.6M |
|
|
IPHI
172
DELISTED
INPHI CORPORATION
IPHI
| $56.2M | 0.14% |
478,373
+298,679
| +166% | +$31.4M |
|
|
JBGS
173
JBG SMITH
JBGS
$659M
| $55.6M | 0.14% |
1,881,285
-65,045
| -3% | -$2.02M |
|
|
GTM
174
ZoomInfo Technologies
GTM
$1.22B
| $55.3M | 0.14% |
+1,084,200
| New | +$51.8M |
|
175
Prudential Financial
PRU
$41.2B
| $54.8M | 0.14% |
899,221
-11,985
| -1% | -$704K |
|
Similar funds
Federated Hermes's Q2 2020 Portfolio in Review
As of Q2 2020, Federated Hermes held 2,489 positions worth $40.4B, up 19% from $34B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2020 filing shows 261 new, 810 increased, 1,082 reduced and 259 closed positions. Its largest new stake was ZoomInfo Technologies: 1,084,200 shares worth $55.3M. The largest sale was Gilead Sciences, an estimated $378M.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Technology and Consumer Discretionary.
- Federated Hermes's largest Q2 2020 buy was ZoomInfo Technologies: 1,084,200 shares worth $55.3M.
- Federated Hermes added most to IBM in Q2 2020, an estimated $245M increase.
- Federated Hermes's biggest Q2 2020 reduction was Gilead Sciences, cutting an estimated $378M.
- Federated Hermes fully exited Invesco in Q2 2020, selling an estimated $62.7M.
- Federated Hermes's ten largest holdings make up 16% of its $40.4B portfolio in Q2 2020.
- Federated Hermes opened 261 new positions and closed 259 in Q2 2020.
- Federated Hermes's portfolio value rose 19% quarter-over-quarter to $40.4B.
Based on Federated Hermes's 13F filing for Q2 2020, filed 13 Aug 2020.